Results 11 to 20 of about 48,636 (248)

HETEROLOGOUS IMMUNITY STUDIES IN CALVES IN IRAN [PDF]

open access: yesIranian Journal of Public Health, 1976
In a series of heterologous immunity studies S. haematobium, S. bovis and O. turkestanicum in calves, a large number of S. haematobium cercariae (21,000 cercariae) were used repeatedly as the immunization agent.
J. Massoud
doaj   +3 more sources

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension [PDF]

open access: yesInternational Journal of Molecular Sciences, 2017
Shakti Singh   +2 more
exaly   +2 more sources

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination

open access: yesVaccines, 2023
With concerns about the efficacy of repeat annual influenza vaccination, it is important to better understand the impact of priming vaccine immunity and develop an effective vaccination strategy. Here, we determined the impact of heterologous prime-boost
Noopur Bhatnagar   +8 more
doaj   +1 more source

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2

open access: yesVaccines, 2021
Coronavirus Disease 2019 (COVID-19) pandemic, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the global challenge. Reaching global herd immunity will help end the COVID-19 pandemic.
Tzu-Chuan Ho   +8 more
doaj   +1 more source

Heterologous vaccine interventions: boosting immunity against future pandemics

open access: yesMolecular Medicine, 2021
While vaccines traditionally have been designed and used for protection against infection or disease caused by one specific pathogen, there are known off-target effects from vaccines that can impact infection from unrelated pathogens.
Daniela Marín-Hernández   +2 more
doaj   +1 more source

Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein

open access: yesVaccines, 2023
(1) Background: As the COVID-19 pandemic enters its fourth year, it continues to cause significant morbidity and mortality worldwide. Although various vaccines have been approved and the use of homologous or heterologous boost doses is widely promoted ...
Dandan Li   +9 more
doaj   +1 more source

Private aspects of heterologous immunity [PDF]

open access: yesThe Journal of Experimental Medicine, 2005
Clinical manifestations of viral infections are highly variable, both in type and severity, among individual patients. Differences in host genetics and in dose and route of infection contribute to this variability but do not fully explain it. New studies now show that each subject's history of past infections individualizes the memory T cell pool ...
Rehermann, B, Shin, EC Shin, Eui-Cheol
openaire   +3 more sources

Diverse Routes of Allograft Tolerance Disruption by Memory T Cells

open access: yesFrontiers in Immunology, 2020
Memory T lymphocytes constitute a significant problem in tissue and organ transplantation due their contribution to early rejection and their relative resistance to tolerance-promoting therapies.
Ronald G. Gill, Adam L. Burrack
doaj   +1 more source

SPECIFIC HETEROLOGOUS ENHANCEMENT OF IMMUNE RESPONSES [PDF]

open access: yesThe Journal of Experimental Medicine, 1971
Abstract A soluble factor which enhanced the plaque-forming antibody response against sheep erythrocytes was found in tissue culture fluid of spleen cell cultures from mice injected with tetanus toxoid 1 to 2 months earlier to which 1 ng of toxoid was added on the 2nd day of a 5-day period of incubation. Such enhancement was demonstrated
Rubin, A S, Coons, A H
openaire   +6 more sources

Home - About - Disclaimer - Privacy